» Articles » PMID: 16514281

Identification of Novel Leishmania Major Antigens That Elicit IgG2a Response in Resistant and Susceptible Mice

Overview
Specialty Parasitology
Date 2006 Mar 4
PMID 16514281
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Experimental murine models with high, intermediate and low levels of genetically based susceptibility to Leishmania major infection reproduce almost entire spectrum of clinical manifestations of the human disease. There are increasing non-comparative studies on immune responses against isolated antigens of L. major in different murine strains. The aim of the present study was to find out whether there is an antigen that can induce protective immune response in resistant and susceptible murine strains. To do that, crude antigenic extract of procyclic and metacyclic promastigotes of L. major was prepared and subjected to SDS-PAGE electrophoresis. Western-blotting was used to search for antigen(s) capable of raising high antibody level of IgG2a versus IgG1 in the sera of both infected resistant and susceptible strains. Two novel antigens from metacyclic promastigotes of L. major (140 and 152 kDa) were potentially able to induce specific dominant IgG2a responses in BALB/c and C57BL/6 mice. The 2 antigens also reacted with IgG antibody of cutaneous leishmaniasis patients. We confirm that 140 and 152 kDa proteins of L. major promastigotes are inducing IgG production in mice and humans.

Citing Articles

Ox40L-Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major.

Tuladhar R, Oghumu S, Dong R, Peterson A, Sharpe A, Satoskar A Exp Parasitol. 2014; 148:49-55.

PMID: 25447125 PMC: 4474147. DOI: 10.1016/j.exppara.2014.11.002.


Th1 Platform Immune Responses Against Leishmania major Induced by Thiol-Specific Antioxidant-Based DNA Vaccines.

Tabatabaie F, Mahdavi M, Faezi S, Dalimi A, Sharifi Z, Akhlaghi L Jundishapur J Microbiol. 2014; 7(2):e8974.

PMID: 25147675 PMC: 4138682. DOI: 10.5812/jjm.8974.


Purification and biochemical characterization of two novel antigens from Leishmania major promastigotes.

Zeinali M, Ardestani S, Kariminia A Korean J Parasitol. 2008; 45(4):287-93.

PMID: 18165711 PMC: 2532619. DOI: 10.3347/kjp.2007.45.4.287.


Protective effect of lectin from Synadenium carinatum on Leishmania amazonensis infection in BALB/c mice.

Afonso-Cardoso S, Rodrigues F, Gomes M, Silva A, Rocha A, Guimaraes A Korean J Parasitol. 2008; 45(4):255-66.

PMID: 18165707 PMC: 2532627. DOI: 10.3347/kjp.2007.45.4.255.

References
1.
Trujillo C, Ramirez R, Velez I, Berberich C . The humoral immune response to the kinetoplastid membrane protein-11 in patients with American leishmaniasis and Chagas disease: prevalence of IgG subclasses and mapping of epitopes. Immunol Lett. 2000; 70(3):203-9. DOI: 10.1016/s0165-2478(99)00146-7. View

2.
Kelly B, Locksley R . The Leishmania major LACK antigen with an immunodominant epitope at amino acids 156 to 173 is not required for early Th2 development in BALB/c mice. Infect Immun. 2004; 72(12):6924-31. PMC: 529165. DOI: 10.1128/IAI.72.12.6924-6931.2004. View

3.
Rafati S, Salmanian A, Hashemi K, Schaff C, Belli S, Fasel N . Identification of Leishmania major cysteine proteinases as targets of the immune response in humans. Mol Biochem Parasitol. 2001; 113(1):35-43. DOI: 10.1016/s0166-6851(00)00377-7. View

4.
Brito M, Mendonca M, Gomes Y, Jardim M, Abath F . Dynamics of the antibody response in patients with therapeutic or spontaneous cure of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 2001; 95(2):203-6. DOI: 10.1016/s0035-9203(01)90168-3. View

5.
Aragort De Rossell R, Calcagno M, Rossell O, Maizo De Segnini Z, Rodriguez A . Intralesional isotype profiles in human localized cutaneous leishmaniasis lesions. Int J Exp Pathol. 2001; 82(2):129-34. PMC: 2517705. DOI: 10.1111/j.1365-2613.2001.iep0082-0129-x. View